Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FGFR1 |
| Variant | D647N |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | FGFR1 D647N lies within the protein kinase domain of the Fgfr1 protein (UniProt.org). D647N demonstrates ATP affinity similar to wild-type Fgfr1 (PMID: 37778450), but results in increased ligand-independent phosphorylation of Fgfr1 (PMID: 34826586, PMID: 37778450), downstream signaling, migration, invasion, and angiogenesis in culture (PMID: 37778450). |
| Associated Drug Resistance | |
| Category Variants Paths |
FGFR1 mutant FGFR1 act mut FGFR1 D647N |
| Transcript | NM_023110.3 |
| gDNA | chr8:g.38414817C>T |
| cDNA | c.1939G>A |
| Protein | p.D647N |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_006716303.3 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| XM_017013221.1 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| XM_017013221.2 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| XM_006716304.2 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| NM_023110.3 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| NM_023110.2 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| XM_006716303.4 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| XM_006716304.1 | chr8:g.38414817C>T | c.1939G>A | p.D647N | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| FGFR1 D647N | breast cancer | sensitive | Erdafitinib | Preclinical - Cell culture | Actionable | In a preclinical study, Balversa (erdafitinib) treatment resulted in decreased Fgfr1 phosphorylation in a cell line expressing FGFR1 D647N and reduced migration in breast cancer cells expressing FGFR1 D647N in culture (PMID: 37778450). | 37778450 |